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It has recently been established that the thymus plays a fundamental role in 
developmental immunobiology (1-3),  a  role  that  is most important in  early 
life, before birth and immediately thereafter, but continues into  adult life (4). 
Mice thymectomized immediately after birth are extremely defective in rejecting 
allogeneic skin or tumor grafts (2, 4, 5) and even xenogeneic skin (6). Their responsive 
antibody formation is also greatly impaired (6-8), although not necessarily for all 
antigens (8). These animals often develop a wasting syndrome, with failure of body 
growth and early mortality (6, 8-10), and are extremely susceptible to the runt dis- 
ease produced by administration of aUogeneic lymphoid cells  (9-11).  Furthermore, 
the lymphoreticular cells derived from neonatally thymectomized mice are defective 
with respect to their capacity to elicit graft versus host reactions (12, 13). These ani- 
mals also have a low level of circulating lymphocytes, a depletion of lymphocytes in 
the tissues,  and, to a somewhat lesser degree, a depletion of plasma cells (2, 6, 8-11, 
13). The immunologic defect, lymphoid cell  depletion, and growth failure of these 
animals can be prevented by grafting a newborn thymus into the subcutaneous tissue 
(11) or by administration, shortly after thymectomy, of adult lymph node cells from 
syngeneic donors  (13, 14). 
Some of the  characteristics of the  mice thymectomized at birth have also  been 
described  in other species subjected to neonatal thymectomy: the rat (15-17),  rabbit 
(3,  10,  18), and  hamster  (19-22).  Particularly  interesting  are  the  findings  in  the 
thymectomized hamster in which a wasting syndrome associated with hypogamma- 
globulinemia  has been observed (19). 
Thymectomy after the immediate neonatal period does not cause wasting in mice, 
although it still has a significant  effect on the development of immunologic reactivity 
as the animal matures. In certain strain combinations, isogenie at the tI-2 histocom- 
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patibility locus, thymectomy  as late as 30 to 40 days of age permits prolonged survival 
and even permanent takes of allogeneic skin and tumor grafts (4, 10, 23), andin certain 
F1 hybrid mice thymectomy at this age increases the susceptibility  to graft versus 
host reaction induced by administration of lymphoid ceils from parental strain ani- 
mals (10). It has also been reported that mice (24) and rabbits (25, 26) thymectomized 
as adults and given a sublethal dose of whole body x-irradiation show decreased ability 
to recover from the immunologic impairment imposed by the irradiation.  Finally, it 
has recently been found that mice thymectomized at 3 to 4 weeks of age and given 
900 roentgens of x-irradiation at 10 weeks show markedly deficient recovery of lymph- 
oid structure of the spleen as compared to normal irradiated controls (27). 
In studies  reported  by Miller  (11, 13,  14), attempts to reconstitute neonatally 
thymectomized  mice with thymic extracts or free thymus ceils have failed, but al- 
logeneic thymic grafts have provided  both physiologic and immunologic restoration. 
Using T6 chromosome marker systems,  as well as immunologic parameters,  it has 
been shown that the cellular reconstitution  which is accomplished by the allogeneic 
thymus grafts is primarily of host origin (14). 
It is the purpose of this paper to present additional experiments seeking a bet- 
ter understanding of the immunologic and developmental deficiencies encoun- 
tered in mice thymectomized  at an early age. It will be shown that lymphoreficu- 
lar cells from mice thymectomized between the 1st and 35th days of life are 
deficient in immunologic function as revealed in studies of the graft versus host 
reaction, and that the degree of deficiency is inversely correlated with age at 
thymectomy. The deficiency of the cells from animals thymectomized on the 
1st day of life is extreme; however, there is a residuum of immunologic activity, 
evident in the runting model when the dosage of cells is quadrupled. Further, 
it will be shown that spleen cells from adult mice thymectomized immediately 
after birth are capable of inducing immunologic tolerance upon injection into 
allogeneic newborn recipients without inducing graft versus host reactions. We 
will also show that the wasting syndrome which regularly develops in neonatally 
thymectomized mice can be  prevented  by administration of suspensions  of 
syngeneic viable thymus or spleen cells,  or by transplanting newborn thymus 
tissue. Immunologic capacity can be restored by grafting thymus tissue from 
neonatal or adult donors, and, as assayed in the graft ~ersus host reaction, full 
immunologic competence is restored by transplantation of neonatal thymus 
as well as by intravenous injection of large numbers of syngeneic adult spleen 
cells. Finally, we will demonstrate that immunologic restoration of neonatally 
thymectomized mice  achieved  by grafting allogeneic  thymus acts  primarily 
through development of the host's own lymphoid cells, with a relatively small 
component of the lymphoid cells of thymus donor origin presumably derived 
from the thymus transplant.  By contrast, the lesser degree of restoration of 
immunologic function achieved by allogeneic spleen grafts is attributable instead 
to the donor tissue of the transplant. A.  P.  DALMASS%  C.  MARTINEZ,  K.  SJODIN~ R.  A.  GOOD  1091 
Materials and Methods 
Mice.--Inbred mice of the A, CsI-I/Bi, C~TB1/1, and DBA/2 strains, and the (A X  C~TB1/1), 
(CsI-I X  Cs~B1/1), and (C~r-I X  DBA/2)Fx hybrids were used in these experiments. All were 
separated  from the mouse colonies  of the late Dr. John J. Bittner in 1956, and have been 
maintained in our own colonies  since that time by rigorous inbreeding procedures. The de- 
tails of housing and care of the animals were given in an earlier paper  (10). 
Thyraectomy.--The thymus was removed, under ether anesthesia, by a method similar to 
that of Dischier and Rudali  (28).  In preparing sham-operated mice, the thorax was opened 
but the thymus left intact. 
Thymus Grafl4ng.--Mice thymectomized on the 1st day of life were grafted subcutaneously 
2 days later with thymus from either 2-day-old or 2-month-old donors. One thymic lobe from 
the newborn donors or an equivalent amount of tissue from the 2-month-old donors was sliced 
into 3 or 4 pieces and introduced into the subcutaneous tissue of each axillary region of the 
recipients. In other experiments spleen from 2-month-old donors was grafted in the same way 
into neonatally thymectomized mice. 
Skin GrafHng.--Full thickness abdominal skin wasplaced on the back of the tested animals 
by the technique  employed as routine in  this laboratory  (29).  Survival of the  grafts  was 
judged by gross inspection. 
Cell-Free Tiss~ Ex~racts.--Thymus or spleen taken from 2- to 4-week-old CaI-I mice was 
mechanically disrupted by a glass tissue homogenizer (Potter-Elvehjem) with a tight fitting 
pestle. Approximately 15 ml of Ringer's lactate saline solution per gm of tissue was used. The 
homogenate was then centrifuged at 3000  ~M for 15 minutes, and  the supernate  stored at 
--20°C for a  few days until used. In one experiment a  thymus extract, described by Szent- 
Gyorgyi eta/.  (30)  and  designated  "promine,  ''1 was  employed. 
Cell Suspens/ons.--Suspeusions  of cells from thymus,  spleen, and lymph nodes were pre- 
pared in Ringer's lactate saline solution, again using a Potter-Elvehjem homogenizer but with 
a  loose fitting pestle. Further  dissociation of the  cells was  completed by  passing  the  sus- 
pension gently in and out of a 27 gauge needle. Suspensions  to be injected intravenously were 
washed  once with Ringer's lactate saline solution employing low speed centrifugation  (500 
m,~) for 15 minutes in an International No. 2 centrifuge. Cell counts were made and dilutions 
prepared so that 10 million nucleated cells were contained in 0.05 to 0.10 ml. The suspensions 
were injected into the orbital branch of the anterior facial vein in the newborn mice and into 
the tail vein of the 40-day-old animals. 
Assay of Graft versus Host AcHeity.--In  one group of experiments the spleen assay of graft 
versus host reaction of Simonsen et d.  (31) was used. This assay assesses  the spleen enlarge- 
ment induced in young F1 hybrid recipients of lymphoid cells from one of the parent strains. 
Litters of 6 to 8 hybrid mice were injected at 8 days of age with spleen or lymph node cells 
from: (a)  syngeneic mice, (b) sham-thymectomlzed or non-operated mice of one of the parent 
strains, or (c) thymectomized mice of the same parent strain used in b. Eight days after cell 
administration the animals were sacrificed,  their body and spleen weights recorded, and the 
relative spleen  weight  (rag/10  gm  body  weight)  determined.  Finally,  the  "spleen index" 
was calculated by dividing the mean relative spleen weight of the animals receiving parent 
strain  cells from  non-thymectomized  mice or  from  thymectomized  animals  by  the  mean 
relative spleen weight of the mice injected with cells from syngeneic donors. 
In another  group  of experiments,  the mortality assay  of the graft versus host reaction, 
described by BiUingham and Brent (32) and by Siskind and Thomas (33) was employed. For 
this  purpose  newborn  mice  were  injected  with  spleen cells derived from  allogeneic  thy- 
1 The  authors  are indebted  to  Dr.  Albert  Szent-Gyorgyi who generously provided  this 
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mectomized or sham-operated animals, and the number of runts as well as the number of 
animals dying between the 5th and 30th days after cell administration was recorded. 
Discriminant Assay o/Call Chimerism.--Adult mice thymectomized at birth and subse- 
quently grafted with allogeneic thymus or spleen tissue were studied by the discriminating 
spleen assay of graft versus host activity described by Simonsen and Jansen (34) to assess the 
immunologic capacity of their spleen and lymph node ceils and to determine the immuno- 
genetic composition of these tissues. At 2 to 4 months of age, the spleen or lymph nodes from 
the mice bearing allogeneic thymus grafts were made into suspensions,  and the host and donor 
components studied in appropriate 6- to 8-day-old Fx hybrid mice. In thymectomized A mice 
grafted with C~H lymphoid tissues, the host component (A) was assayed in the (A X C~TB1)FI 
hybrid and the donor component (C3H) in the (C3H X Cs~B1)F1 hybrid. Only litters of 6 to 8 
animals were employed, and in each experiment negative controls were prepared by injecting 
some of the FI members with cells  from mice syngeneic with a component of the chimera that 
was expected to be rejected by the hybrid; e.g., A into (car X C~TB1)F1.  The dosage of cells 
in the controls was always the same as that used to assay the components of the chimera: 
in most cases 10 million cells, but in some instances 20 to 30 million ceils, as indicated in the 
data. Two positive controls of the litter were given 10 million ceils from normal animals syn- 
geneic with the component of the chimera that was expected to be accepted by and to react 
against the F1 hybrid; e.g., A into (A X  CsTB1)Fz. Test animals were sacrificed 8 days later, 
and their body and spleen weights determined. A relative spleen weight was then calculated 
(rag/10 gm body weight) and a mean value determined for each group (experimental, positive 
control, and negative control). The "experimental spleen index" was calculated by dividing 
the mean relative spleen weight of the experimental group by the mean relative spleen weight 
of the negative controls. In the same  manner, the "control spleen index" was calculated by 
dividing the mean value of positive controls by the mean value of the negative controls. 
RESULTS 
Spleen Assay of Graft versus Host Activity of Spleen Cells Derived from  Mice 
Thymectomized  at Different  Ages.-- 
In the first group of experiments, the spleen assay of graft versus  host reaction was employed 
to compare the immunologic impairment produced by thymectomy performed at different 
ages. CaI-I  mice thymectomized at 1, 6, 14, 25, and 35 days of age were sacrificed 2 or 6 months 
following thymectomy. A cell suspension was prepared from the spleen of each animal, and 
10 million of the cells administered intraperitoneally to (CsH X DBA/2)FI hybrid recipients 
which were killed 8 days later. Spleen cells from normal C3H mice sacrificed at 14 days, 35 
days, and 2 to 3 months of age were also tested and served as controls. 
It will be seen in Fig. 1 that, as measured in this way, spleen cells from un- 
thymectomized mice of the  C~I strain show progressive development of im- 
munologlc capacity during the first 3 months of life. The older the CeI-I mice 
the greater  the splenomegaly produced by injection of their spleen cells into 
(C3H  ×  DBA/2)F~ recipients. Very little splenomegaly followed the injection 
of the spleen cells from 14-day-old donors. The splenomegaly was greater when 
the spleen cells were taken from 35-day-old animals, and a  2- to 3-fold increase 
in the  spleen index was  observed in hybrid recipients of  cells from  2-  to  3- 
month-old donors approximating the characteristic activity of adult cells. 
These results also show clearly that thymectomy on the  1st, 6th, and 14th I 
I  I  I  I 
0  0  0  0 
0  In  o. 
X3ONI  N337dS 
1093 
'-~  o  "0 
~  o~. 
•  0 
0 1094  P~ECONSTITUTIOIq O1  ~  TM'MUNOLOGIC CAPACITY 
day of life virtually abolishes the capacity of the spleen cells of the C~I-I animal 
to produce graft versus host reactions in this model. Definite suppression  of 
immunologic reactivity was also observed when cells from mice thymectomized 
as late as 25 or 35 days of age were injected into the hybrid recipients. Both of 
these groups,  tested at about 3 months of age, showed a marked deficiency 
when compared to unoperated mice 2 to 3 months of age; rather, their cells 
had immunologic  activity in the Simonsen assay approximating that of un- 
thymectomized control animals sacrificed at 35 days of age. 
Another point of interest in Fig.  1 is the finding that cells from mice thy- 
mectomized 6 days after birth were incompetent in the Simonsen graft versus 
host assay when tested both 2 and 6 months after thymectomy. This observa- 
tion indicates that the completely thymectomized mouse of this strain does 
not recover immunologic capacity over a 6 month period  when the capacity 
for immune reaction is tested in this way. Fig.  1 also shows that the spleen 
cells of mice thymectomized at 25 days of age have greater immunologic ca- 
pacity than those  thymectomized at 1, 6, or  14 days, and that this greater 
immunologic  reactivity is present whether the animals are tested at 2  or 6 
months after thymectomy. Thus, when thymectomy is carried out during de- 
velopment but after the establishment of a degree of immunologic competence 
of the peripheral  lymphoid tissues,  the attained level  of immune capability 
remains where it was at the time of thymectomy: this degree of competence 
is not lost, but neither do the animals "catch up" to the unthymectomized 
control  animals  in the maturation of immunologic function of the peripheral 
lymphoid tissues.  The effect of thymectomy has a  degree of permanence  in 
mice, and the level of immune activity of the splenic tissue  of such animals 
reflects the age at which thymectomy was performed. 
Effect of Thymectomy on Capacity of Spleen Cells to Produce Immunologic Runt 
Disease.-- 
In the second group of experiments, the presence of immunologically competent cells in 
the spleens of mice thymectomized at  1 to 24 hours of age was studied by determining the 
incidence of immunologic runting among newborn mice injected with allogeneic adult spleen 
cells obtained from neonatally thymectomized donors at 2 months of age. Two strain com- 
binations were used: C57B1 donors and A hosts, and A strain donors and Call hosts. In the 
basic study 5 million cells were administered intravenously. When this dosage failed to produce 
runt disease, an additional study was performed involving administration of 20 million cells 
from C57B1 donors to newborn A recipients. The results are recorded in Table I. 
It will be seen in this table that, in both strain combinations, 5 million spleen 
cells from neonatally thymectomized animals failed to produce runting in the 
newborn  recipients.  To the contrary, 5  million spleen cells from 2-month-old 
donors not subjected to neonatal thymectomy regularly produced runt disease A. P.  DALMASSO, C. MARTINEZ, K.  SJODIN,  R.  A. GOOD  1095 
and early death in the neonatal recipients. That this defect in the spleen cells of 
neonatally  thymectomized animals is  quantitative  rather  than  qualitative  is 
shown in the experiments involving a larger inoculum of cells. When 20 million 
cells from 2-month-old C57Bl mice that had been thymectomized at birth were 
administered intravenously to newborn A  hosts, 5  of 11  recipients developed 
characteristic  evidence of runt  disease. 
We  conclude  from these experiments that  the peripheral lymphoid tissues 
(spleen) of mice thymectomized in the newborn period are markedly defective 
in  their  ability to produce graft versus  host  reactions.  The defect is relative, 
TABLE  I 
Effect of Neonatal Thymectomy on Capacity of Spleen Cells to Produce  Run~ 
Disease in Allogene~ Mi~e 
No. of cells  Recipient  Donor  Previous treatment  injected  Incidence of 
strain  strain  of donor  (million)  runt disease* 
A  C57B1/1 
Cstt 
Sham-thymectomy 
Neonatal thymectomy 
Neonatal thymectomy 
Sham-thymectomy 
Neonatal thymectomy 
5 
5 
20 
0 
27/28 
1/29 
S/11 
0/18 
13/31 
1/61 
0/36 
* Immunologic runt  disease indicated  by characteristic  runting  syndrome followed by 
death between days 5 and 30 after cell administration. Numerator equals number of animals 
that died, and denominator the number of animals in the group. 
however; if a  sufficiently large inoculum is employed, some  immunologic re- 
activity of spleen cells from neonatally thymectomized animals can be demon- 
strated. 
Induction  of  Immunologic  Tolerance  with Spleen  Cells from  Mice  Thymec- 
tomized  at  Birtk.-- 
The surviving mice from the experiments in the preceding section (A mice injected with 
CsTB1 spleen cells, and Call mice receiving A strain spleen cells) were grafted at 6 to 7 weeks 
of age with skin taken from normal animals of the same strain as the cell donors. The results 
are shown in Table II. 
The mice of the A strain, recipients of spleen cells from C57B1 mice at birth, 
were not tolerant of C57B1 skin. In fact, with the exception of 2 mice that kept 
the grafts for 55 to 60 days, the rejection time was about the same as that of 
non-injected control animals. 1096  RECONSTITUTION  OF  IMMUNOLOGIC  CAPACITY 
On the other hand, in the C~I mice injected at birth with spleen cells from 
either normal or thymectomized A strain mice, long lasting tolerance  (survival 
of skin for 6 months or more)  was achieved  in a  similar  proportion of both 
groups, 61 per cent of the mice receiving cells from normal donors and 58 per 
cent of the animals receiving cells from thymectomized donors. 
Attempts to Reconstitute  Neonatally  Thymectomized  Mice with Cell-Free Ex- 
tracts.--Mice thymectomized at birth are frequently defective  in growth, as- 
sume a hunched posture, and die at an early age. As indicated earlier, when the 
TABLE  II 
Induction of Immunologic. Tolerance ~itlt Spleen Cells  from Mice Thymedemized 
at Birth 
Recipient 
strain 
A 
C3H 
Donor 
strain 
CsTB1/1 
A 
Previous tresement 
of donor 
None 
Neonatal thymectomy 
Neonatal thymectomy 
None 
Neonatal thymectomy 
No. of  cells 
injected 
(mfllion) 
5 
5 
20 
0 
Incidence of 
tolerance* 
o/It 
i/is§ 
i/s§ 
o/Is 
ll/18 
33/57 
0/34 
* Tolerance indicated by the number d  mice accepting skin graft from the str~n of mice 
donating the cells at birth. 
Twenty-seven of 28 A strain animals injected with C~BI spleen cells soon died of runt 
disease. 
§ These 2 animals kept the homografts for 55 to 60 days and then the grafts were finally 
rejected. 
thymectomy  has been complete, such mice accept skin grafts across both weak 
and strong histocompatibility barriers.  The observations  reported above es- 
tablish that the peripheral  lymphoid tissues  (spleen) of mice thymectomized 
as late as 35 days of age are defective with respect to capacity to induce graft 
vers~ host reactions. 
To determine whether treatment with cell-free thymic or splenic extracts might reconstitute 
neonatally thymectomized animals,  three experiments were performed.  In the first experi- 
ment, mice were given repeated subcutaneous injections (3 times a week for 6 weeks beginning 
at 3 days of age) of an aqueous thymic extract, and the incidence of wasting disease compared 
with that of untreated neonatally thymectomized animals. In the second experiment, groups 
of mice thymectomized at 6 and 14 days of age were treated with aqueous extracts of either 
thymus or spleen, given 6 days a week for 6 weeks beginning at 1 month of age, and the graft 
~ers~ host activity of their spleen ceils compared with that of untreated animals thymec- 
tomized at the same ages. Finally, 6 mice thymectomized at 6 days of age were given "pro- A. P.  DALMASSO,  C. MARTINEZ,  K. SJODIN,  R. A. GOOD  1097 
mine," an extract of thymus prepared by Szent-Gyorgyi and associates,  in a  dosage  of 0.25 
ml daily for 15 consecutive days beginning at 1 month of age, followed, after 10 days, by a 
test of graft versus host activity of their spleen cells compared to that of appropriate controls. 
The results of these experiments are summarized in Tables III and IV. 
TABLE III 
Effect of Aqueous Extract of Thymus on Wasting Syndrome in Mice 
Group  . 
Call mice, thymectomized at birth, given aqueous thymic ex-  I 
tract* .................................................  ] 
CaI-I mice, thymectomized at birth, not treated ...............  I 
C3H mice, sham-operated ..................................  I 
Incidence of wasting disease 
11/14 (78 per cent)$ 
17/21  (81 per cen0 
0/24 
* Complete thymectomy in neonatal period,  0.1  ml saline extract of thymus from syn- 
geneic mice, begun at 3 days of age and continued 3 times per week for 2 weeks, and then 
0.25 cc given subcutaneously 3 times per week over next 4 weeks. 
Mice showed growth failure, hunched posture, and died before 4 months of age. 
TABLE IV 
Effect of Aqueous Extract of Thymic Tissue and Promine on Immunologic Capacity 
of P~pheral Lymphoid  Tissue of Thymectomizcd Call Mice 
Immunologic activity of 
Group  Treatment  spleen cells in Simonsen's 
graft ~rsus host reaction* 
days 
Thymectomy, 6 ............... 
Thymectomy, 14 .............. 
Thymectomy, 6 ............... 
Thymectomy, 14 .............. 
Thymectomy, 6 ............... 
Thymectomy, 6 ............... 
Thymectomy, 14 .............. 
Sham-operated ................ 
Thymus extract~ 
Thymus extract 
Spleen extract 
Spleen extract 
Promine§ 
None 
None 
O/4 
O/4 
O/4 
O/4 
O/5 
O/lO 
o/5 
10/10 
* Mice were tested for graft versus host reactions by the spleen assay technique of Simon. 
sen. Animals were sacrificed  10 days following  the last injection of aqueous spleen extract 
and spleen cells  tested  in (Call  X  DBA/2)F1 animals. A  positive spleen index for  these 
experiments are litters with a spleen index of 1.40 or greater; mice whose spleen index falls 
below this value are considered negative. 
Subcutaneous injections of aqueous extracts of thymus or spleen from mice 2 to 3 weeks 
of age were given in a dosage  of 0.25 ml 6 times a week for a period of 6 weeks. 
§ Injections of "promine" (Szent-Gyorgyi) were begun at 1 month of age and given sub- 
cutaneously in a dosage of 0.25 ml for 15 consecutive days. 
As shown in Table III, C~H mice thymectomized at birth and treated with an 
aqueous thymic extract for 6  weeks showed an incidence of wasting and early 
death  (before 4  months of age) comparable to control animals thymectomized 
at birth but not given thymus extract.  Sham-operated  Call mice kept under 
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On Table IV are recorded observations which indicate that aqueous extracts 
of splenic or thymic tissue did not restore immunologic capacity of the spleen 
cells of mice thymectomlzed at 6  or  14 days of age. It is also apparent that 
Dr.  Szent-Gyorgyi's compound,  promine,  shown  to  be  a  growth-promoting 
factor present in high concentration in the thymus, did not restore immunologic 
reactivity of the splenic tissue of mice thymectomized at 6 days of age. 
Effect of Syng~eic Thymus Grafting and Administration of Syngeneic Lymphoid 
Cell Suspensions  on Mice Thymectomi~ed in the Neonatal Period.-- 
Several additional studies were performed in an effort to reconstitute mice thymectomized 
during the first 24 hours after birth. Among the methods used were: intraperitoneal injection 
at 2 days of age of 10 million viable cells from the thymus of 2-day-old donors; intraperitoneal 
injection at 2 days of age of 10 million viable thymus cells from 2-month-old donors; intra- 
peritoneal injection at 2 days of age of 10 million spleen cells from 2-month-old donors; intra- 
venous injection at 40 days of age of 100 million spleen or thymus cells from 2-month-old 
donors; and subcutaneous grafting at 2 days of age with thymus from 2-day-old donors. Three 
comparisons were made: survival to 8 months of age, rejection of aliogeneic skin grafts, and 
capacity of the animal's spleen cells to induce splenomegaly after intraperitoneal injection 
into (CjH X  DBA/2)F, hybrids. 
The results of these experiments are summarized in Table V. It will be seen 
that of the three standards of reconstitution,  the one most uniformly affected 
by treatment was longevity; indeed,  every method used in these experiments 
contributed significantly toward prolongation of life in the neonatally thymec- 
tomized mice, and three of the treatments: intraperitoneal injection of thymus 
cells from 2-day-old donors at 2 days of age, intraperitoneal injection of spleen 
cells from 2-month-old mice at 2 days of age, and intravenous administration 
of spleen cells from 2-month-old donors at 40 days of age, were as effective in 
increasing the life span as was subcutaneous grafting of thymus in the neonatal 
period. 
With  respect  to  the  second  criterion  of  recovery,  rejection of allogeneic 
(DBA/2)  skin  grafts,  the  two  uniformly effective methods  were  grafting  of 
neonatal thymus in the neonatal period and administration of spleen cells from 
2-month-old donors either at 2 or 40 days of age. Injections of suspensions of 
viable thymic cells from neonatal or 2-month-old donors appeared to provide 
very little restoration of capacity to reject skin grafts. 
Finally, reconstitution of capacity of the spleen cells of the thymectomized 
mice to exercise a  graft ~ersus host reaction in hybrid hosts was assessed.  By 
this standard,  grafting of syngeneic thymus and injection  at 40  days of  100 
million spleen cells from 2-month-old donors proved to be most efficient. Much 
less  consistent  evidence  of restoration  of  this  function  was  evidenced  after 
administration of thymus cells,  whether from newborn or 2-month-old donors, 
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definitely effective in restoring immunologic activity of spleen cells, was intra- 
peritoneal injection at 2 days of age of spleen cells from 2-month-old animals. 
Thus,  we conclude that subcutaneous grafting of a  syngeneic thymus, intra- 
peritoneal injection of syngeneic adult spleen cells at an early age, or intravenous 
administration of large numbers of syngeneic adult spleen cells at 40  days of 
TABLE V 
Effeds of Syngenei~ Cells and Thymua Grafts on C~t Mice Thymeaomized in the 
Neonatal Period 
Treatment 
Injection (i.p.) of 10 million 
2-day-old thymus cells .... 
Injection (i.p.) of 10 million 
2-month-old thymus cells.. 
Injection (i.p.) of 10 million 
2-month-old spleen ceils... 
Grafting (subcut.) of 2-day- 
old thymus.. 
Injection (i.v.) of 100 mil- 
lion 2-month-old thymus 
cells... 
Injection (i.v.) of 100 mil- 
lion 2-month-old spleen 
cells.. 
Non-injected thymectomized 
controls. 
Non-injected  unthymec- 
tomized controls. 
Age 
when 
treated 
days 
2 
2 
2 
2 
40 
4O 
Survivors  DBA/2  Spleen assay of ~raft 
at  skin  rersus host reaction:~ 
8 months  grafts*  (spleen index) 
p~r 
c~t 
9/10  90 
17/26  73 
19/20  95 
12/14  86 
6/11  55 
12/13  92 
2/15  13 
15/16  94 
4/7  1,00  1.03  1.21  1.45 
6/12  0.98  0.99  1.05  1.22  1.60 
0/12  1.04  1.32  1.45  1.53  1.88  2.0 
0/6  1.60  1.97  2.15  2.48  2.63 
2/5  0.91  1.14  1.19  1.98 
0/6  1.52  1.76  2.14  2.37 
6/8  0.95 to 1.25 (10 mice) 
0/15  1.85 to 3.08  (10 mice) 
* Number  of mice  accepting DBA/2  skin graft for 30  days or more/number of mice 
grafted. 
:~ Spleen assay performed when  animals were 2 to 4 months old by injecting 10 million 
spleen  cells into 8-day-old (Call X  DBA/2)Fx hybrids. Mice were sacrificed 8 days later 
and spleen index calculated as described in Material and Methods. 
age,  will  restore  the  immunologic  capabilities of  neonatally  thymectomized 
rmce by the three criteria used in this evaluation. 
Immunologic  Characteristics  of  Neonatally  Thymectomized  Mice  Bearing 
Allogeneic Thymus Grafts.-- 
In this experiment,  A and C3H mice were thymectomized or sham-operatod on the 1st 
day of life. Two days later, the A anlrn~ls were grafted with thymus from  2-day-old C3B 
donors,  and the C~I-I mice were grafted with thymus from 2-month-old  A donors. Thymec- 
tomized C~:I and sham-operated A and C3H animals served  as controls. ii00  RECONSTITUTION OF  IM~IUNOLOGIC  CAPACITY 
As will be seen in Table VI, the thymectomized A  strain mice grafted with 
neonatal C~-I thymus accepted skin grafts from both A and C~-I donors at 35 
days of age, but regularly rejected skin from DBA/2 animals. Similarly, C3I-t 
mice bearing thymus grafts from 2-month-old A  donors  accepted skin from 
both A and CvI-I donors and rejected third party skin from DBA/2 animals in 
every instance. By contrast, control CvI-I  mice thymectomized in the neonatal 
period accepted skin grafts from both A  and DBA/2  donors. As is to be ex- 
pected, intact  CvI-I  and A  strain mice rejected the allogeneic grafts across the 
H-2 barrier in every instance. 
From  these  observations,  it  appears  that mice thymectomized in  the  ira- 
TABLE VI 
Skin tIomograft Survival in Mice Tkymectomized a~ Birth and Grafted Subcutaneously 
2 Days Later with Thymus Gland "tom an Allogene~ Strain 
Groups 
Thymectomized A, grafted with 2-day-old CvH 
thymus ................................... 
Thymectomized C~H, grafted with 2-month-old 
A thymus ................................ 
Thymectomized C~-I, no thymus graft ........ 
Sham-thymectomized C3H, no thymus graft .... 
Sham-thymectomized A, no thymus graft ...... 
Skin grafts* 
A 
8/8  7/s 
8/8  9/9 
7/11 
o/li 
o/lo 
C~-I  DBM2 
1/7 
O/5 
6/8 
0/11 
0/10 
* Number of mice taking the graft for 30 days or more/number of mice grafted. 
mediate neonatal period can be restored to a state of normal or nearly normal 
immunologic reactivity with respect to transplantation immunity by allogeneic 
grafts of thymic tissue, but that the animals become chimeric and thus capable 
of accepting skin grafts from the same strain as that of the thymus donor. 
Immunologic Analysis of the Chimeric  Lymphoid  Tissue of Neonatally  Thy- 
mectomized  Mice Bearing Allogeneic Thymus Grafts.-- 
The next group of experiments was undertaken  to determine whether  the 
immunologic recovery of neonatally thymectomized mice grafted with allogeneic 
thymus tissue reflects recovery of host lymphoid cells or seeding of thymic cells 
to the spleen and lymph nodes where proliferation and immunologic function 
might occur. 
Thymectomy was performed in the neonatal period on a large group d  mice of the A and 
C~-I strains. Each animal received a thymus graft from either a newborn or 2-month-old  donor 
of the other strain. Others were grafted with splenic tissue from 2-month-old  allogeneic donors, 
and still others received xenogeneic thymus grafts from 2-day-old rat donors. The spleens of "E 
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the 2- to 4-month-old animals were assayed for donor and host components  (host component 
only of mice receiving  rat cells) of the presumed chimera using the discriminating spleen 
assay of Simonsen and Jensen (34). As indicated in the section on methods, the cell recipients 
were 8-day-old hybrid mice, (A X  C~TBI)F1  for the crucial host component  of A mice bearing 
4.00- 
5.50- 
3.00 
X  ,.,  2.50 
Q 
Z 
z  to  to  2.00 
¢L 
O3 
6.50 
1.00 
Host  Donor  Host  Donor 
Normal A  Thymectom.  ;)-day-old  thymus (jr.  2-month-old  thymus gr. 
at birth 
non-qrofted  Thymectomized  ot birth  and  cjrofted 
FIG. 3.  Reconstitution of immunologic capacity of lymph node cells of neonatally thy- 
mectornized mice with allogeneic thymus transplants. Here, too, the thymus transplant re- 
constitutes primarily the  host-type immunologic  capacity. 
CsH thymuses, and (C~-I X  Cs~B1)F1 for the host component  of C~-I mice bearing A strain 
thymus tissue.  The spleen index was  calculated for each group. 
The results are summarized in Fig. 2.  The spleen index of normal adult A 
and C~H spleen cells in the appropriate F1 hybrid was always near 2 or greater. 
By  contrast,  mice  thymectomized  in  the  neonatal  period  and  not  treated 
further had spleen indexes of less than  1.3  in every instance. The neonatally 
thymectomized mice grafted in the newborn period with thymus from 2-day-old 
allogenelc donors regularly showed significant restoration of immunologic func- A.  P.  DALMASSO, C.  MARTINEZ,  K.  SJODI_N, R.  A.  GOOD  1103 
tion. In the discriminating spleen assay, we found that the host component was 
predominant,  but that a donor component was also demonstrable in some of 
the animals.  When the transplant was taken from a 2-month-old donor, restora- 
tion of splenic immunologic activity was also accomplished, but the cell ac- 
tivity was less vigorous. Again the restoration was  attributable primarily  to 
development of host cells, although some development of donor  cell activity 
was also noted. 
When allogeneic  spleen tissue from 2-month-old donors was transplanted  to 
neonatally thymectomized mice,  less restoration  of immunologic competence 
occurred, but it was attributable almost entirely to donor ceils. 
Finally, thymus tissue from 2-day-old rats was transplanted  to neonatally 
thymectomized mice. Although these grafts took at first, became vascularized, 
and survived for a time, they failed to restore immunologic competence of the 
host component as determined by the discriminating spleen assay. 
In  the experiments summarized in Fig. 3,  the discriminating  spleen assay 
was again used to determine the relative prominence of the host component 
in the lymph nodes of neonatally thymectomized mice reconstituted with al- 
logeneic thymus grafts from either 2-day-old or 2-month-old donors. As will be 
seen in the figure,  a  marked degree of immunologic restoration occurred, at- 
tributable largely to activity of host cells. However, in 2 of 6 animals receiving 
thymus tissue from 2-day-old donors, a significant  donor component could be 
demonstrated. 
DISCUSSION 
The first group of experiments reported in this study, using the Simonsen 
assay technique,  shows that thymectomy performed even as late as 35 days 
after birth in mice interferes with development of full immunologic competence 
as the animals get older. Indeed, from these data, it seems likely that thymec- 
tomy interferes with the development of the peripheral lymphoid tissues beyond 
the phase of maturation reached by the time the surgery is carried out. Looking 
at these results in another way, it can be reasoned, in support of the earlier 
observations of NIakinodan and Peterson (35), that the immunologic develop- 
ment of the lymphoid tissues in mice continues for a  prolonged period after 
birth and that such development is, at least in part, thymus-dependent. 
It also seems clear from the observations presented here that,  as revealed 
in the graft versus  host assay, mice do not show appreciable recovery of im- 
monologic competence following  thymectomy even though  they are studied 
as long as 6 months later. In this manner mice differ from rabbits. Archer et al. 
(36) have observed recovery from the morphologic deficit produced by neonatal 
thymectomy in rabbits, a  recovery they attribute to the function of the ap- 
pendix in this animal. 
The demonstration in the initial group of experiments that large inocula of 1104  RECONSTITUTION  OF IMMUNOLOGIC  CAPACITY 
spleen  cells  from  neonatally  thymectomized  animals  will  induce  runting  in 
appropriate F1 recipients indicates,  as might be inferred from earlier  work on 
the antibody producing capacity of these animals  (8), that the defect produced 
by neonatal  thymectomy in  the  mouse is  quantitative  and  not  qualitative. 
Further,  the data show clearly that,  although thymectomy at birth interferes 
with the development of immunologic  capacity of splenic tissue, this procedure 
does not interfere demonstrably with the capacity of the splenic  tissue of A 
strain mice to produce immunologic  tolerance in neonatal C3H mice. It has not 
been possible heretofore to induce immunologic  tolerance by injecting neonatal 
A strain mice with C57B1 spleen cells. Instead, a high incidence  of severe runt 
disease regularly follows such cell administration, and any animals surviving are 
not tolerant of Cs~B1 skin (32, 37). 
With the availability of neonatal thymectomy as a  means of reducing  the 
capacity of spleen cells from C57B1 mice to react against the A strain hosts, we 
were hopeful that  finally  tolerance might  be produced in  these  recalcitrant 
strain  combinations. The results were unexpected and perplexing: under  the 
conditions of our study, the A strain mice injected at birth with spleen cells 
from adult Cs~B1 mice thymectomized at birth did not develop immunologic 
tolerance.  Thus,  for reasons as yet unclear,  induction  of tolerance of C~TBI 
skin in A mice is still not possible in our laboratories. 
In the studies reported here,  numerous attempts  to reconstitute the mice 
thymectomized at birth have been carried out. Thus far, none of the cell-free 
materials used has been effective in preventing runt disease and early death, 
or in reinstating immunologic competence. However, such negative results are 
not of great moment,  and  attempts  to find  a  non-cellular  substance of this 
nature in the thymus, which might reveal an endocrinologic  role for this organ, 
must be continued. 
Our studies of syngeneic thymus grafts and injection of isolated syngeneic cells 
from  thymus and  spleen  indicate  that  significant  reconstitufion of thymec- 
tomized mice can be achieved by several methods. Thymus cells from 2-day-old 
or  2-month-old  donors,  spleen  cells  from  2-month-old  donors,  and  grafted 
neonatal  thymus  all  made  possible regular  survival  of neonatally  thymec- 
tomized mice to 8 months. However, restoration of capacity to reject allogeneic 
skin grafts was accomplished by only two methods: transplantation of thymus 
from newborn syngeneic donors and intravenous or intraperitoneal injection of 
spleen cells from adult donors of the same strain.  The findings  regarding  the 
efficacy of neonatal thymus grafts and of neonatal administration of syngeneic 
peripheral lymphoid cells parallel those of Miller (11,  14). He used the C67B1 
strain, rather than the C3H, and administered syngeneic lymph node cells, in a 
dosage of 5 to 10 million cells, on the 5th day of life. Sixty per cent of the animals 
escaped the early death of wasted animals, and all the survivors had adequate 
homograft immunity. Lymphoid cells given after the first week of life had no A.  P.  DALMASSO,  C.  MARTINEZ,  K.  $JODIN,  R.  A.  GOOD  1105 
effect. The appreciably higher rate of survival and the effectiveness of late (40 
days)  administration of spleen cells  in  our studies probably reflects strain 
differences in the severity of the wasting process. The data of Parrott and East 
(8) indicate that animals of both the C~I-I/Bi and C~B1 strains consistently 
develop wasting symptoms after neonatal thymectomy, but that death occurs 
earlier and more precipitately in the C57B1. Parrott and East (8) have prevented 
wasting disease in 11 of 12 C~-I/Bi  mice by administration of 4 to 5 million 
spleen cells intravenously 1 or 2 days after thymectomy. In addition,  they 
restored all 7 neonatally thymectomized mice of this strain grafted with whole 
syngeneic thymus in the kidney capsule in the newborn period. 
Finally, in studies of the reconstitution of the capacity of the spleen cells of 
the neonatally thymectomized mice to  produce graft  versus  host reactions, 
only two of the treatments appeared to give full restoration of function: trans- 
plantation of syngeneic newborn thymus at an early age and intravenous in- 
jection of a large dose of syngeneic spleen cells from an immunologically mature 
animal prior to the onset of wasting disease in the thymectomized recipient. 
Some restoration, of lesser degree, was evident in animals receiving spleen cells 
from a mature donor intraperitoneally at 2 days of age. 
The observations, particularly the efficacy of peripheral lymphoid cells  in 
restoring immunologic capacity, are compatible with  the concept  that  the 
deficiencies of neonatally thymectomize  d  mice reflect a  deficit of peripheral 
lymphoid cells and do not necessarily imply endocrinologic  effects or effects 
other than those attributable to failure of normal development of the lymphoid 
tissue. They would not, however, be inconsistent with the possible operation of 
an endocrinologic function of the thymus. 
Our observations on allogeneic thymus transplantation to neonatally thymec- 
tornized mice agree substantially with those of Miller (11). It is shown that 
neonatally thymectomized mice bearing allogeneic thymus grafts are chimeric 
and able to accept skin grafts from the strain of the thymus donor. The same 
animals are fully capable of rejecting skin grafts from a  third strain. Thus, 
allogeneic thymus grafts appear to be capable of producing full immunologic 
tolerance toward the strain donating the thymus and restoring immunologic 
capacity in the thymectomized host. 
Finally, perhaps the most interesting observations of this series are those 
employing the discriminant spleen assay of Simonsen and Jensen (34) to study 
the immunologic characteristics of the spleen  and lymph node cells of mice 
thymectomized at birth and transplanted with allogeneic thymus grafts from 
2-day-old donors. These results again establish that thymus transplants can 
reconstitute immunologic reactivity of both spleen  and lymph nodes of the 
thymectomized mouse. 
In keeping with Miller's observations (11, 13), using the T6 marker system, 
we found that, quantitatively, the primary reconstitution occurs with respect to 1106  RECONSTITU~ION OF IM2~J'NOLOGIC  CAPACITY 
the host component in the peripheral  lymphoid tissues. However, in some ani- 
mals there is an appreciable  donor component.  By contrast, grafts of spleen 
from  2-month-old  donors  were  less effective  in  restoring  the  immunologic 
capabilities of neonatally thymectomized  mice; however, when such restoration 
occurred  it was attributable entirely to the donor component of the chimera. 
These observations  suggest, certainly, that cells of thymic origin can "periph- 
eralize" to the spleen and lymph nodes, as was first suggested by Beard (38) 
and subsequently reiterated by several  investigators (39-41).  On  the other 
hand, and quantitatively more important, the allogeneic thymus graft appears 
to be essential to development of lymphoid cells which have the immunologic 
characteristics of the host. This finding  could  reflect  a  distant effect of the 
thymus transplant, such as might be expected  of an endocrine  organ,  or it 
could be a  consequence  of direct ceil-to-cell influence, either by the thymus 
cells acting upon splenic mesenchymal cells of the host or by an influence of 
the mesenchymal cells of the host on some of the "peripheralizing" thymic 
cells. Scientific demonstration of any of these several possibilities would be most 
contributory to the understanding of a number of basic biologic processes in 
mammals. 
SUM2JARY 
The immunologic  competence  of spleen cells of mice, as assessed by their 
graft versus host capabilities,  increases to 35 days of age and beyond. Thymec- 
tomy at any point along this continuum of development produces "immunologic 
arrest:" the peripheral  lymphoid tissues of such mice do not show significant 
increases  in activity as the animals mature, nor is there appreciable  loss of 
activity up to 6 months after surgery. 
Adult spleen cells from mice thymectomized at 1 to 24 hours of age have a 
greatly reduced ability to induce  runt disease. Five million spleen cells from 
immunologically  mature animals will uniformly cause  fatal runt disease  in 
neonatal recipients,  but  this same  number of cells from neonatally thymec- 
tomized animals  produces  almost no runt disease. When the dosage of cells 
from neonatally thymectomized C57B1 mice is increased  to 20 million, about 
half of the A recipients develop runt disease. Thus, the defect is a quantitative 
one. 
Spleen cells from neonatally thymectomized mice will induce tolerance  of 
skin grafts from the donor strain. In one recalcitrant strain combination, C~TB1 
to A, use of spleen cells from neonatally thymectomized  donors as the tolerance- 
inducing inoculum permits survival of the recipients,  which usually die with 
severe runt disease, but does not induce tolerance. 
Cell free extracts of spleen and thymus tissue, including "promine" of Szent- 
Gyorgyi et al.,  did not affect the runting syndrome or the immunologic reac- 
tivity of neonatally thymectomized mice. A. P. DALMASSO,  C. MARTINEZ,  K. SJODIN, It. A. GOOD  1107 
When syngeneic thymic tissue is grafted  into neonatally  thymectomized  mice, 
or the animals are given viable syngeneic spleen or thymus cells, the majority of 
the animals escape the early mortality characteristic of this group.  Adminis- 
tration of syngeneic  spleen ceils from adult donors and grafting of syngeneic 
neonatal thymus provide restoration of homograft immunity and graft versus 
host reactivity of the peripheral  lymphoid tissues  in most of the neonatally 
thymectomized animals.  Thymus cells rarely provide significant  restoration 
of these parameters. 
Allogeneic thymus grafts also restore neonatally thymectomized  mice. Such 
animals are chimeric: the immunologically competent cells of their peripheral 
lymphoid tissues are chiefly of host origin as determined by the discriminant 
spleen  assay, but in many instances a  significant  donor component is  also 
demonstrable in this system. These chimeric animals accept skin gra/ts from 
both donor and host strains. 
A degree of reconstitution has also been attained by grafting of allogeneic 
adult spleen in neonatally thymectomized animals. The discriminant spleen 
assay indicates that cells of the donor strain predominate in the peripheral 
lymphoid tissues of such mice. 
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